Entity Central Index Key Lessee opearting lease liability payments due in five years and thereafter. Cover [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Period Focus Document Fiscal Period Focus Document Fiscal Year Focus Document Fiscal Year Focus Entity Registrant Name Entity Registrant Name Entity Central Index Key Trading Symbol Trading Symbol Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Common Stock, Shares Outstanding Entity Common Stock Shares Outstanding Entity Current Reporting Status Entity Current Reporting Status Entity Interactive Data Current Entity Interactive Data Current Entity Shell Company Entity Shell Company Entity Ex Transition Period Entity Ex Transition Period Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address, Address Line Two Entity Address Address Line2 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Title of 12(b) Security Security12b Title Security Exchange Name Security Exchange Name Entity Incorporation, State or Country Code Entity Incorporation State Country Code Document Quarterly Report Document Quarterly Report Document Transition Report Document Transition Report Accrued clinical and research and development expenses. Statement Of Financial Position [Abstract] Assets Assets [Abstract] Current assets: Assets Current [Abstract] Cash and cash equivalents Cash And Cash Equivalents At Carrying Value Accounts receivable Accounts Receivable Net Current Prepaid expenses Prepaid Expense Current Other current assets Other Assets Current Total current assets Assets Current Property, equipment, and software—net Property Plant And Equipment Net Intangible assets—net Intangible Assets Net Excluding Goodwill Right-of-use assets—net Operating Lease Right Of Use Asset Investment in equity securities Equity Securities F V N I Noncurrent Equity method investment Equity Method Investments Note receivable—net Notes Receivable Net Other assets Other Assets Noncurrent Total assets Assets Liabilities and Stockholders’ Equity Liabilities And Stockholders Equity [Abstract] Current liabilities: Liabilities Current [Abstract] Accounts payable Accounts Payable Current Accrued compensation Employee Related Liabilities Current Accrued clinical and research and development expenses Accrued Clinical And Research And Development Expenses Deferred revenue Contract With Customer Liability Current Lease liabilities Operating Lease Liability Current Other current liabilities Other Liabilities Current Total current liabilities Liabilities Current Deferred revenue Contract With Customer Liability Noncurrent Lease liabilities Operating Lease Liability Noncurrent Long term debt—net Long Term Debt Contract liabilities Business Combination Contingent Consideration Liability Other noncurrent liabilities Other Liabilities Noncurrent Total liabilities Liabilities Commitments and contingencies (Note 4) Commitments And Contingencies Stockholders’ equity: Stockholders Equity [Abstract] Preferred stock, $0.0001 par value— 10,000,000 shares authorized as of June 30, 2022 and December 31, 2021; no shares issued and outstanding as of June 30, 2022 and December 31, 2021 Preferred Stock Value Common stock; $0.000005 par value— 200,000,000 shares authorized as of June 30, 2022 and December 31, 2021; 111,605,505 shares issued and 110,795,033 shares outstanding as of June 30, 2022; 61,712,577 shares issued and 60,902,105 shares outstanding as of December 31, 2021 Common Stock Value Additional paid-in capital Additional Paid In Capital Common Stock Accumulated deficit Retained Earnings Accumulated Deficit Treasury stock Treasury Stock Value Total stockholders’ equity Stockholders Equity Total liabilities and stockholders’ equity Liabilities And Stockholders Equity Preferred stock, par value Preferred Stock Par Or Stated Value Per Share Preferred stock, shares authorized Preferred Stock Shares Authorized Preferred stock, shares issued Preferred Stock Shares Issued Preferred stock, shares outstanding Preferred Stock Shares Outstanding Common stock, par value Common Stock Par Or Stated Value Per Share Common stock, shares authorized Common Stock Shares Authorized Common stock, shares issued Common Stock Shares Issued Common stock, shares outstanding Common Stock Shares Outstanding Income Statement [Abstract] Revenue Revenue From Contract With Customer Excluding Assessed Tax Operating expenses Operating Expenses [Abstract] Research and development Research And Development Expense General and administrative General And Administrative Expense Total operating expenses Operating Expenses Operating (loss) income Operating Income Loss Other (expense) income: Other Nonoperating Income Expense [Abstract] Loss from equity method investment Income Loss From Equity Method Investments Interest expense Interest Expense Interest income Investment Income Interest Total other (expense) income, net Other Nonoperating Income Expense Net (loss) income Net Income Loss Net (loss) income per share Earnings Per Share Basic And Diluted [Abstract] Basic Earnings Per Share Basic Diluted Earnings Per Share Diluted Weighted average shares of common stock outstanding Weighted Average Number Of Shares Outstanding [Abstract] Basic Weighted Average Number Of Shares Outstanding Basic Diluted Weighted Average Number Of Diluted Shares Outstanding Stock issued during period collaboration partners, shares. Stock Issued During Period, Value, Collaboration Partners. Statement Of Stockholders Equity [Abstract] Statement [Table] Statement [Table] Additional Paid-in Capital Statement Equity Components [Axis] Equity Component Equity Component [Domain] Common Stock Common Stock [Member] Additional Paid-in Capital Additional Paid In Capital [Member] Accumulated Deficit Retained Earnings [Member] Treasury Stock Treasury Stock [Member] Statement [Line Items] Statement [Line Items] Beginning balance Beginning balance, Shares Stock option exercises Stock Issued During Period Value Stock Options Exercised Stock option exercises, Shares Stock Issued During Period Shares Stock Options Exercised Issuance of common stock under employee stock purchase plan Stock Issued During Period Value Employee Stock Purchase Plan Issuance of common stock under employee stock purchase plan, Shares Stock Issued During Period Shares Employee Stock Purchase Plans Share-based compensation expense Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Proceeds from issuance of common stock, net of issuance cost Stock Issued During Period Value New Issues Proceeds from issuance of common stock, net of issuance cost, Shares Stock Issued During Period Shares New Issues Issuance of common stock to collaboration partners Stock Issued During Period Value Collaboration Partners Issuance of common stock to collaboration partners, Shares Stock Issued During Period Collaboration Partners Shares Restricted stock units vested Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures Restricted stock units vested, Shares Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures Net income (loss) Ending balance Ending balance, Shares Amortization of discount on note receivable. Increase decrease in other assets and other current assets. Increase decrease in accrued other expenses and other current liabilities. Increase (decrease) in lease liability and right to use asset other than amortization, net. Increase decrease in contract liability. Proceeds from employee stock purchase plan Unsettled at-the-market issuances of common stock included in other current assets. Contract liability accrual related to Servier Program Purchase Agreement milestones. Statement Of Cash Flows [Abstract] Cash flows from operating activities: Net Cash Provided By Used In Operating Activities [Abstract] Net (loss) income Profit Loss Adjustments to reconcile net (loss) income to net cash used in operating activities: Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Depreciation and amortization Depreciation And Amortization Share-based compensation Share Based Compensation Loss on disposal of assets Gains Losses On Sales Of Assets Non-cash interest expense Amortization Of Debt Discount Premium Amortization of right-of-use assets Operating Lease Right Of Use Asset Amortization Expense Loss from equity method investment Amortization of discount on note receivable Amortization Of Discount On Note Receivable Changes in operating assets and liabilities: Increase Decrease In Operating Capital [Abstract] Prepaid expenses Increase Decrease In Prepaid Expense Accounts receivable Increase Decrease In Accounts Receivable Other assets and other current assets Increase Decrease In Other Assets And Other Current Assets Accounts payable Increase Decrease In Accounts Payable Other liabilities and other current liabilities Increase Decrease In Accrued Other Expenses And Other Current Liabilities Deferred revenue Increase Decrease In Contract With Customer Liability Lease liabilities and right-of-use assets Increase Decrease In Lease Liability And Right To Use Asset Other Than Amortization Net Contract liabilities Increase Decrease In Contract Liability Net cash (used in) provided by operating activities Net Cash Provided By Used In Operating Activities Cash flows from investing activities: Net Cash Provided By Used In Investing Activities [Abstract] Purchases of property, equipment and software Payments To Acquire Productive Assets Net cash used in investing activities Net Cash Provided By Used In Investing Activities Cash flows from financing activities: Net Cash Provided By Used In Financing Activities [Abstract] Proceeds from stock option exercises Proceeds From Stock Options Exercised Proceeds from employee stock purchase plan Proceeds From Employee Stock Purchase Plan Proceeds from offering of common stock, net of issuance costs Proceeds From Issuance Of Common Stock Proceeds from issuance of common stock to collaboration partners Proceeds From Minority Shareholders Borrowings from revolving credit facility, net of issuance costs paid to lender Proceeds From Long Term Lines Of Credit Proceeds from issuance of term loan, net of issuance costs paid to lender Proceeds From Debt Net Of Issuance Costs Payments of debt issuance costs Payments Of Debt Issuance Costs Net cash provided by financing activities Net Cash Provided By Used In Financing Activities Net increase in cash and cash equivalents Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Cash and cash equivalents—beginning of period Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Cash and cash equivalents —end of period Supplemental disclosures of noncash activities: Cash Flow Noncash Investing And Financing Activities Disclosure [Abstract] Property, equipment and software additions included in accounts payable and accrued expenses other current liabilities Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 Common stock issuance costs included in accrued expenses Payments Of Stock Issuance Costs Cash paid for interest Interest Paid Net Unsettled at-the-market issuances of common stock included in other current assets Unsettled At The Market Issuances Of Common Stock Included In Other Current Assets Contract liability accrual related to Servier Program Purchase Agreement milestones Contract Liability Accrual Related To Servier Program Purchase Agreement Milestones Organization Consolidation And Presentation Of Financial Statements [Abstract] DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Text Block] Stockholders Equity Note [Abstract] STOCKHOLDERS' EQUITY Stockholders Equity Note Disclosure [Text Block] Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] SHARE-BASED COMPENSATION Disclosure Of Compensation Related Costs Share Based Payments [Text Block] Commitments And Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Commitments And Contingencies Disclosure [Text Block] Debt Disclosure [Abstract] DEBT Debt Disclosure [Text Block] Income Tax Disclosure [Abstract] INCOME TAXES Income Tax Disclosure [Text Block] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Abstract] FAIR VALUE MEASUREMENTS Fair Value Measurement Inputs Disclosure [Text Block] The entire disclosure of deconsolidation of subsidiary. Deconsolidation of subsidiary. Deconsolidation Of Subsidiary [Abstract] Elo Transaction Deconsolidation Of Subsidiary Disclosure [Text Block] COLLABORATION AND LICENSE AGREEMENTS Collaborative Arrangement Disclosure [Text Block] Earnings Per Share [Abstract] NET (LOSS) INCOME PER SHARE Earnings Per Share [Text Block] Segment Reporting [Abstract] SEGMENT REPORTING Segment Reporting Disclosure [Text Block] Revenue Recognition for Contracts with Customers Revenue From Contract With Customer Policy [Text Block] Schedule of Stock-Based Compensation Expense Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block] Schedule of Stock-Based Compensation Expense Schedule Of Compensation Cost For Share Based Payment Arrangements Allocation Of Share Based Compensation Costs By Plan Table [Text Block] Schedule of Stock Options Valuation Assumptions Using a Black-Scholes Option Pricing Model Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block] Summary of Activity of Option Plans Schedule Of Share Based Compensation Stock Options Activity Table [Text Block] Summary of Restricted Stock Unit Activity Schedule Of Share Based Compensation Restricted Stock Units Award Activity Table [Text Block] Schedule of Future Lease Payments under Non-Cancelable Leases Lessee Operating Lease Liability Maturity Table [Text Block] Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Table [Text Block] Schedule of Earnings Per Share, Basic and Diluted Schedule Of Earnings Per Share Basic And Diluted Table [Text Block] Schedule of Common Share Equivalent Securities Excluded from Calculation of Diluted Net (Loss) Income per Share Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block] Description of business and summary of significant accounting policies. Description of business and summary of significant accounting policies. Description Of Business And Summary Of Significant Accounting Policies [Table] Description Of Business And Summary Of Significant Accounting Policies [Table] Ownership Ownership [Axis] Ownership Ownership [Domain] Precision PlantSciences, Inc. Precision PlantSciences, Inc Precision Plant Sciences Inc [Member] Precision Bio Sciences UK Limited. Precision BioSciences UK Limited Precision Bio Sciences U K Limited [Member] Collaborative Arrangement and Arrangement Other than Collaborative Type Of Arrangement [Axis] Collaborative Arrangement and Arrangement Other than Collaborative Arrangements And Nonarrangement Transactions [Member] Novartis agreement. Novartis Agreement Novartis Agreement [Member] Statistical Measurement Range [Axis] Statistical Measurement Range [Member] Maximum Maximum [Member] Minimum [Member] Minimum [Member] Description Of Business And Summary Of Significant Accounting Policies [Line Items] Description Of Business And Summary Of Significant Accounting Policies [Line Items] Date of incorporation Entity Incorporation Date Of Incorporation Percentage owned in subsidiary Minority Interest Ownership Percentage By Parent Underwriting discounts and commission. Offering price Shares Issued Price Per Share Underwriting discounts and commission Underwriting Discounts And Commission Upfront cash payment Proceeds From Collaborators Revenue for changes in total estimated time to be incurred in the future to satisfy the performance obligation Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized Revenue recorded included in deferred revenue Contract With Customer Liability Revenue Recognized The maximum number of of common and preferred stock shares permitted to be issued by an entity's charter and bylaws. Common and preferred stocks, shares authorized Common And Preferred Stocks Shares Authorized Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Plan Name Plan Name [Axis] Plan Name Plan Name [Domain] Two Thousand Six and Two Thousand Fifteen Stock Incentive Plan. 2006 and 2015 Plan Two Thousand Six And Two Thousand Fifteen Stock Incentive Plan [Member] Two thousand nineteen incentive award plan. 2019 Plan Two Thousand Nineteen Incentive Award Plan [Member] Award Type Award Type [Axis] Award Type Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain] Restricted Stock Units Restricted Stock Units R S U [Member] Two thousand nineteen employee stock purchase plan. 2019 ESPP Two Thousand Nineteen Employee Stock Purchase Plan [Member] Employee Stock Purchase Plan ESPP Employee Stock Purchase Plan [Member] Inducement award plan member. Inducement Award Plan Inducement Award Plan [Member] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Options outstanding Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Remaining shares available to be granted Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Share based compensation arrangement by share based payment award number of shares available for issuance. Allowed annual percentage increase in shares authorized as percentage of outstanding shares of common stock. Number of shares available for issuance Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Issuance Number of shares available to be issued Common Stock Capital Shares Reserved For Future Issuance Allowed annual percentage increase in shares authorized as percentage of outstanding shares of common stock Allowed Annual Percentage Increase In Shares Authorized As Percentage Of Outstanding Shares Of Common Stock RSU outstanding Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number Increase in common stock available for issuance. Number of shares issued under employee stock purchase plans. Increase in common stock available for issuance Increase In Common Stock Available For Issuance Maximum shares allowed to be issued under ESPP Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized Purchase of common stock through payroll deductions expressed in percentage of fair market value Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent Total number of shares issued under 2019 ESPP Numberof Shares Issued Under Employee Stock Purchase Plans Share based compensation expense Allocated Share Based Compensation Expense Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Title of Individual Title Of Individual [Axis] Title of Individual Title Of Individual With Relationship To Entity [Domain] Employee Share Based Payment Arrangement Employee [Member] Nonemployee Share Based Payment Arrangement Nonemployee [Member] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Share-based compensation expense Income Statement Location Income Statement Location [Axis] Income Statement Location Income Statement Location [Domain] Research and Development Research And Development Expense [Member] General and Administrative General And Administrative Expense [Member] Stock Option Employee Stock Option [Member] Share based compensation arrangement by share based payment award fair value assumptions weighted average fair value per option. Estimated dividend yield Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Weighted-average expected stock price volatility Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Weighted-average risk-free interest rate Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Expected term of options (in years) Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 Weighted-average fair value per option Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Fair Value Per Option Outstanding Option Shares, Beginning Balance Option, Granted Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Option, Exercised Option, Forfeited/canceled Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Outstanding Option Shares, Ending Balance Weighted-Average Exercise Price Outstanding at Beginning Balance Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Weighted-Average Exercise Price, Granted Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price Weighted-Average Exercise Price, Exercised Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price Weighted-Average Exercise Price, Forfeited/canceled Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price Weighted-Average Exercise Price Outstanding at Ending Balance Intrinsic value of Stock options exercised Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value Share based compensation arrangement by share based payment award options grant date fair value. Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted Share Based Compensation Arrangement By Share Based Payment Award Options Grant Date Fair Value Share Based Compensation Arrangement By Share Based Payment Award Options Grant Date Fair Value Unvested RSUs as of January 1, 2022 Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares Forfeited Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations Vested Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares Unvested RSUs as of June 30, 2022 Weighted-Average Grant Date Fair Value, Beginning Balance Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value Weighted-Average Grant Date Fair Value, Granted Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value Weighted-Average Grant Date Fair Value, Forfeited Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value Weighted-Average Grant Date Fair Value, Vested Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value Weighted-Average Grant Date Fair Value, Ending Balance Unrecognized compensation cost Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options Weighted-average period for recognition of compensation cost Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 Product development and commercialization period 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Line items represent commitments and contingencies. Commitment and contingencies. Commitment And Contingencies [Table] Commitment And Contingencies [Table] Balance Sheet Location Balance Sheet Location [Axis] Balance Sheet Location Balance Sheet Location [Domain] Contract liabilities. Contract Liabilities Contract Liabilities [Member] Supply Agreements [Member]. Supply Agreements Supply Agreements [Member] Commitments And Contingencies [Line Items] Commitments And Contingencies [Line Items] Contract liabilities Loss Contingency Accrual At Carrying Value Product development and commercialization period Product Development And Commercialization Period Operating Leases Future Minimum Payments Due [Abstract] 2022 (excluding the six months ended June 30, 2022) Lessee Operating Lease Liability Payments Remainder Of Fiscal Year 2023 Lessee Operating Lease Liability Payments Due Next Twelve Months 2024 Lessee Operating Lease Liability Payments Due Year Two 2025 Lessee Operating Lease Liability Payments Due Year Three 2026 Lessee Operating Lease Liability Payments Due Year Four 2027 and beyond Lessee Operating Lease Liability Payments Due In Five Years And Thereafter Total lease payments Lessee Operating Lease Liability Payments Due Less: imputed interest Lessee Operating Lease Liability Undiscounted Excess Amount Total operating lease liabilities Operating Lease Liability Agreement termination notice period. Agreement termination notice period Agreement Termination Notice Period Debt Instrument [Table] Debt Instrument [Table] Elo Loan. Elo Loan Elo Loan [Member] Pacific western loan agreement. Pacific Western Loan Agreement Pacific Western Loan Agreement [Member] Credit Facility Credit Facility [Axis] Credit Facility Credit Facility [Domain] Revolving Credit Facility Revolving Credit Facility [Member] Seventh amendment to revolving line. Seventh Amendment to Revolving Line Seventh Amendment To Revolving Line [Member] Subsequent Event Type Subsequent Event Type [Axis] Subsequent Event Type Subsequent Event Type [Domain] Subsequent Event Subsequent Event [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Loan amount Debt Instrument Face Amount Aggregate principal amount Line Of Credit Facility Current Borrowing Capacity Required balance of unrestricted cash at bank Compensating Balance Amount Proceeds from lines of credit Proceeds From Lines Of Credit Basis point added to the prime rate Debt Instrument Basis Spread On Variable Rate1 Interest rate during period Debt Instrument Interest Rate Stated Percentage Maturity of line of credit Line Of Credit Facility Expiration Date1 Borrowings Line Of Credit Facility Maximum Amount Outstanding During Period Unamortized revolving line debt discount balance Debt Instrument Unamortized Discount Effective interest rate Debt Instrument Interest Rate Effective Percentage Income tax disclosure. Income tax disclosure. Income Tax Disclosure [Table] Income Tax Disclosure [Table] Scenario Statement Scenario [Axis] Scenario Scenario Unspecified [Domain] Forecast Scenario Forecast [Member] Income Tax Disclosure [Line Items] Income Tax Disclosure [Line Items] Effective income tax rate Effective Income Tax Rate Continuing Operations Uncertain tax positions Liability For Uncertain Tax Positions Current Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Equity issuance agreement. Equity Issuance Agreement Equity Issuance Agreement [Member] Counterparty Name Counterparty Name [Axis] Counterparty Name Repurchase Agreement Counterparty Name [Domain] iECURE member. iECURE I E C U R E [Member] Amendment to Revolving Line Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Investment in equity securities Assets Fair Value Disclosure Change in fair value of debt fees. Borrowings Change in fair value of debt fees Change In Fair Value Of Debt Fees Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Table] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Table] Asset Class Fair Value By Asset Class [Axis] Asset Class Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain] Money Market Funds Money Market Funds [Member] Fair Value Hierarchy and NAV Fair Value By Fair Value Hierarchy Level [Axis] Fair Value Hierarchy and NAV Fair Value Measurements Fair Value Hierarchy [Domain] Level 1 Fair Value Inputs Level1 [Member] Level 2 Fair Value Inputs Level2 [Member] Level 3 Fair Value Inputs Level3 [Member] Measurement Frequency Fair Value By Measurement Frequency [Axis] Measurement Frequency Fair Value Measurement Frequency [Domain] Fair Value Measurements Recurring Fair Value Measurements Recurring [Member] Investment Type Investment Type [Axis] Investments Investment Type Categorization [Member] Repurchase Agreements Repurchase Agreements [Member] Investment in iECURE member. Investment in iECURE Investment In I E C U R E [Member] Liability Class Fair Value By Liability Class [Axis] Fair Value by Liability Class Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation By Liability Class [Domain] Success fee. Success Fee Success Fee [Member] Final payment fee. Final Payment Fee Final Payment Fee [Member] Assets Liabilities Financial Liabilities Fair Value Disclosure Disclosure - Elo Transaction - Additional Information (Details) [Abstract] Disclosure Elo Transaction Additional Information Details [Abstract] Deconsolidation of subsidiary. Deconsolidation Of Subsidiary [Table] Deconsolidation Of Subsidiary [Table] Deconsolidation Of Subsidiary [Table] Debt Instrument Debt Instrument [Axis] Debt Instrument, Name Debt Instrument Name [Domain] Promissory Note. Promissory Note Promissory Note [Member] Consolidated Entities Consolidated Entities [Axis] Consolidated Entities Consolidated Entities [Domain] New Elo. New Elo New Elo [Member] Deconsolidation Of Subsidiary [Line Items] Deconsolidation Of Subsidiary [Line Items] Notes received Receivable With Imputed Interest Face Amount Debt instrument maturity date Debt Instrument Maturity Date Fair value of promissory note at acquisition Proceeds From Notes Payable Promissory note discount Receivable With Imputed Interest Discount Percentage of voting shares owned Equity Method Investment Ownership Percentage Percentage of premium over the volume-weighted-average-price of the company’s common stock. Number of trading days. Upfront compensation Transaction price allocated to the revenue arrangement Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table] Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table] Research and Development Arrangement, Contract to Perform for Others, Type Research And Development Arrangement Contract To Perform For Others By Type [Axis] Research and Development Arrangement, Contract to Perform for Others, Type Research And Development Arrangement Contract To Perform For Others Type [Domain] Research and Development Arrangement Research And Development Arrangement [Member] Novartis Pharma A.G. Novartis Pharma AG Novartis Pharma A G [Member] Sale of Stock Subsidiary Sale Of Stock [Axis] Sale of Stock Sale Of Stock Name Of Transaction [Domain] Stock purchase agreement member Stock Purchase Agreement Stock Purchase Agreement [Member] Current liabilities. Current Liabilities Current Liabilities [Member] Eli lilly and company member. Eli Lilly and Company Eli Lilly And Company [Member] Program Purchase Agreement Program Purchase Agreement Program Purchase Agreement [Member] Servier Servier Servier [Member] Development and commercial license agreement. Development And Commercial License Agreement Development And Commercial License Agreement [Member] Collaboration and License Agreements [Line items] Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] Equity method investments Sale of stock, number of shares issued in transaction Sale Of Stock Number Of Shares Issued In Transaction Aggregate purchase price Sale Of Stock Consideration Received Per Transaction Sale of stock, price per share Sale Of Stock Price Per Share Percentage of premium over the volume-weighted-average-price of the company’s common stock Percentage Of Premium Over Volume Weighted Average Price Of Company S Common Stock Number of trading days Number Of Trading Days Upfront Compensation Upfront Compensation Equity upon the issuance of the shares Adjustments To Additional Paid In Capital Stock Issued Issuance Costs Transaction price allocated to the revenue arrangement Transaction Price Allocated To The Revenue Arrangement Sale of stock, description of transaction Sale Of Stock Description Of Transaction Aggregate Potential Milestone Payments Receivable Obligation to pay royalties expiry date. Milestone payments to be received for additional targets Aggregate Potential Milestone Payments Receivable Obligation to pay royalties expiry date Obligation To Pay Royalties Expiry Date Transaction price from the stock purchase agreement Transaction price from the Stock Purchase Agreement Transaction Price From The Stock Purchase Agreement Deferred revenue related to agreement Contract With Customer Liability Investment in equity securities Equity Securities Fv Ni Prepaid Expense and Other Assets Prepaid Expense And Other Assets Other Assets Other Assets Waiver of milestone payment. Waiver of milestone payment Waiver Of Milestone Payment Net (loss) income (in thousands) Basic weighted average common shares Dilutive impact of share-based awards Incremental Common Shares Attributable To Share Based Payment Arrangements Diluted weighted-average common shares Basic net (loss) income per share Diluted net (loss) income per share Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Antidilutive Securities Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis] Antidilutive Securities, Name Antidilutive Securities Name [Domain] Unsettled employee stock purchase plan contributions. Unsettled ESPP Contributions Unsettled Employee Stock Purchase Plan Contributions [Member] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive common share equivalents Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount Number of reportable segments Number Of Reportable Segments